Meeting Wed, 04/21/2021 - 12:00 Drug Utilization Review Board Meeting Information

Date
Media
Edit Implementation Schedule March 2021
PDL Announcement March 2021
PDL Recommendations 04-18-2021
Agenda
DUR Agenda 04-21-2021
Minutes
DUR Minutes 4-21-2021 Approved
Criteria
DUR Criteria
Conduent Reports
Media
MO User Statistics
DUR Criteria
Clinical Edit Proposals – No New Criteria
Media
Acne or Rosacea Select Topical Agents March 2021
Givlaari March 2021
Megestrol March 2021
Sickle Cell Disease March 2021
Zulresso March 2021
DUR Criteria
Clinical Edit Proposals – New or Revised Criteria
Media
CFTR March 2021
Clobazam Agents March 2021
Fabry Disease March 2021
Nocturnal Polyuria March 2021
Opioids Single Agent Short Acting March 2021
Oxlumo March 2021
Spravato March 2021
DUR Criteria
Preferred Drug List Edit Proposals – Existing Criteria
Media
Actinic Keratosis Agents Topical March 2021
Antifungals Oral March 2021
Antihistamines Intranasal March 2021
Antihistamines Decongestant Combos 2nd Gen March 2021
Antivirals Oral March 2021
Antivirals Topical March 2021
Benzoyl Peroxide Antibiotic Combinations March 2021
Beta Adrenergic Agents Long Acting March 2021
Beta Adrenergic Agents Nebulized March 2021
Cough Cold Preparations March 2021
Fluoroquinolones Ophthalmic March 2021
Mast Cell Stabilizers Ophthalmic March 2021
NSAIDS Ophthalmic March 2021
Pancreatic Enzymes March 2021
Psoriasis Agents Oral March 2021
Psoriasis Agents Topical March 2021
Retinoids Topical March 2021
Ulcerative Colitis Agents Rectal March 2021
DUR Criteria
Preferred Drug List Edit Proposals – New or Revised Criteria
Media
Androgenic Agents March 2021
Antibiotics Inhaled March 2021
Antifungals Topical March 2021
Antihistamines Ophthalmic March 2021
Antiparasitics Topical March 2021
Atopic Dermatitis Agents Immunomodulators March 2021
Beta Adrenergic Agents Short Acting March 2021
COPD Agents March 2021
Corticosteroids Inhaled March 2021
Corticosteroids Intranasal March 2021
Corticosteroids Ophthalmic Soft March 2021
Corticosteroids Topical March 2021
Epinephrine Agents Self Injectable March 2021
Fluoroquinolones Otic March 2021
Glaucoma Agents March 2021
Hepatitis C Agents March 2021
Hereditary Angioedema March 2021
Leukotriene Receptor Modifiers March 2021
Respiratory Monoclonal Antibodies March 2021
Ulcerative Colitis Agents Oral March 2021
Page
Drug Utilization Review Board Meeting Information